{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-027358","form_type":"8-K","ticker":"SCNX","cik":"0001382574","company_name":"Scienture Holdings, Inc.","filed_at":"2022-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.384325+00:00","generated_at":"2026-06-23T05:52:51.046299+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"TRxADE Health appoints Jeff Newell to Board of Directors, effective Sept 30, 2022","bullets":["Jeff Newell appointed to fill board vacancy left by Christine L. Jennings' Aug 26 resignation.","Newell joins Audit, Compensation, and Nominating/Governance committees.","Previously served on Advisory Board for $3,000/month; consulting agreement terminated upon appointment.","Newell brings over 40 years healthcare experience, including CEO at Pharmacy Quality Solutions and Kmart Pharmacy.","Board now has majority independent directors and fully constituted three-member Audit Committee."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-027358","json":"https://secwatch.observer/filing/0001493152-22-027358.json","markdown":"https://secwatch.observer/filing/0001493152-22-027358.md","text":"https://secwatch.observer/filing/0001493152-22-027358.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1382574/000149315222027358/0001493152-22-027358-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1382574/000149315222027358/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T05:52:51.046299+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"56010ef7b1","claim":"Jeff Newell was appointed as Director at Scienture Holdings, Inc..","evidence_excerpt":"On September 30, 2022, the Board of Directors of TRxADE HEALTH, INC. (“ TRxADE ”, the “ Company ”, “ we ” and “ us ”), with the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors, appointed Mr. Jeff Newell as a member of the Board of Directors, with such appointment to take effect immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315222027358/0001493152-22-027358-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}